Results 41 to 50 of about 519,655 (258)

Long COVID: An overview

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
Long COVID is the collective term to denote persistence of symptoms in those who have recovered from SARS-CoV-2 infection.WE searched the pubmed and scopus databases for original articles and reviews. Based on the search result, in this review article we are analyzing various aspects of Long COVID.Fatigue, cough, chest tightness, breathlessness ...
A.V. Raveendran, Rajeev Jayadevan, S. Sashidharan   +2 more
openaire   +2 more sources

APPLICATION OF DATA MINING FOR PREDICTION OF LONG COVID ON COVID-19 SURVIVAL WITH FEATURE SELECTION AND NAÏVE BAYES METHOD [PDF]

, 2022
Since it was declared a global pandemic in March 2020, Corona Virus Disease (Covid-19) has become the world's attention, a lot of research has focused on all things related to Covid-19.
Rokhmah, Siti, Rozaq Rais, Nendy Akbar
core   +2 more sources

The Risk Factors of Long COVID in the Acute COVID and Solid Organ Transplant Retrospective Cohorts [PDF]

, 2022
Background: Coronavirus disease 2019 (COVID-19) in solid organ transplant (SOT) patients is associated with more severe outcomes than non-immunosuppressed hosts.
Nyandemoh, Ahmed
core   +1 more source

Policy brief: identifying mental health support gaps for people living with Long COVID [PDF]

, 2023
Long COVID can be both physically daunting and emotionally laden. We recognise that it is important to support the mental health of people living with Long COVID, alongside medical interventions.
Adan, Noa, Baz, Sarah, Carpentieri , JD, Fang, Chao, Sheard, Laura, Walter, Elizbeth, Wielar, Lily   +6 more
core   +2 more sources

Long COVID clinical evaluation, research and impact on society: a global expert consensus

Annals of Clinical Microbiology and Antimicrobials
Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There are few recommendations, and no formal training exists for medical professionals to assist with clinical evaluation and management of ...
Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, Anna E. S. Brooks, Julien Wist, Yaneer Bar-Yam, Stephane Bilodeau, Jennifer Curtin, Rae Duncan, Mark Faghy, Leo Galland, Etheresia Pretorius, Spela Salamon, Danilo Buonsenso, Claire Hastie, Binita Kane, M. Asad Khan, Amos Lal, Dennis Lau, Raina MacIntyre, Sammie McFarland, Daniel Munblit, Jeremy Nicholson, Hanna M. Ollila, David Putrino, Alberto Rosario, Timothy Tan, The Long COVID consensus expert panel (Table S1)   +27 more
doaj   +1 more source

Overview of molecular signatures of senescence and associated resources: pros and cons

FEBS Open Bio, EarlyView.
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas, Sylvia Vagena, Pavlos Pantelis, Giorgos Theocharous, Russel Petty, Konstantinos Evangelou, Vassilis G. Gorgoulis   +6 more
wiley   +1 more source

SARS-CoV-2-on-Chip for Long COVID Management

Biosensors, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a “wicked evil” in this century due to its extended progression and huge human mortalities.
Jayesh Cherusseri, Claire Mary Savio, Mohammad Khalid, Vishal Chaudhary, Arshid Numan, Sreekanth J. Varma, Amrutha Menon, Ajeet Kaushik   +7 more
doaj   +1 more source

Post‐COVID Fatigue Is Associated With Reduced Cortical Thickness After Hospitalization

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuropsychiatric symptoms are among the most prevalent sequelae of COVID‐19, particularly among hospitalized patients. Recent research has identified volumetric brain changes associated with COVID‐19. However, it currently remains poorly understood how brain changes relate to post‐COVID fatigue and cognitive deficits.
Tim J. Hartung, Florentin Steigerwald, Amy Romanello, Cathrin Kodde, Matthias Endres, Sandra Frank, Peter Heuschmann, Philipp Koehler, Stephan Krohn, Daniel Pape, Jens Schaller, Sophia Stöcklein, Istvan Vadasz, Janne Vehreschild, Martin Witzenrath, Thomas Zoller, Carsten Finke, on behalf of the NAPKON Study Group, Y. Ahlgrimm, C. Finke, J. Fricke, T. Keil, L. Krist, N. Lisewsky, M. Mittermaier, M. Mueller‐Plathe, C. Pley, S. Schmidt, A. Stege, F. Steinbeis, S. Steinbrecher, C. Wildberg, M. Witzenrath, E. Zessin, T. Zoller, C. Arendt, C. Bellinghausen, S. Cremer, A. Groh, A. Gruenewaldt, Y. Khodamoradi, S. Klinsing, G. Rohde, M. Vehreschild, T. Vogl, S. Frank, J. C. Hellmuth, M. Huber, S. Kaeaeb, O. T. Keppler, E. Khatamzas, C. Mandel, S. Mueller, M. Muenchhoff, L. Reeh, C. Scherer, H. Stubbe, M. von Bergwelt, L. Weiss, B. Zwissler, S. Cleef, M. E. Figuera Basso, J. Franzenburg, K. Franzpoetter, A. Friedrichs, A. Hermes, J. Heyckendorf, C. Kujat, I. Lehmann, C. Maetzler, S. Meier, D. Pape, S. Poick, L. Reinke, A. K. Russ, A. M. Scheer, D. Schunk, T. Tamminga, S. Bohnet, D. Droemann, K. F. Franzen, R. Hoerster, N. Kaeding, M. Nissen, P. Parschke, J. Rupp, S. Caesar, H. Einsele, S. Frantz, A. Frey, A. Grau, K. Haas, C. Haertel, K. G. Haeusler, G. Hein, J. Herrmann, A. Horn, R. Jahns, P. Meybohm, F. A. Montellano, C. Morbach, J. Schmidt, P. Schulze, S. Stoerk, J. Volkmann, T. Bahmer, A. Hermes, M. Krawczak, W. Lieb, S. Schreiber, T. Tamminga, B. Balzuweit, S. Berger, J. Fricke, M. Hummel, A. Krannich, L. Krist, F. Kurth, J. Lienau, R. Lorbeer, C. Pley, J. Schaller, S. Schmidt, C. Thibeault, M. Witzenrath, T. Zoller, I. Bernemann, T. Illig, M. Kersting, N. Klopp, V. Kopfnagel, S. Muecke, M. Kraus, B. Lorenz‐Depiereux, G. Anton, A. Kuehn‐Steven, S. Kunze, M. K. Tauchert, K. Appel, M. Brechtel, I. Broehl, K. Fiedler, R. Geisler, S. M. Hopff, K. Knaub, C. Lee, S. Nunes de Miranda, S. Raquib, G. Sauer, M. Scherer, J. J. Vehreschild, P. Wagner, L. Wolf, J. C. Hellmuth, K. Guenther, F. Haug, J. Haug, A. Horn, M. Kohls, C. Fiessler, P. U. Heuschmann, O. Miljukov, C. Nuernberger, J. P. Reese, L. Schmidbauer, I. Chaplinskaya, S. Hanss, D. Krefting, C. Pape, M. Rainers, A. Schoneberg, N. Weinert, T. Bahls, W. Hoffmann, M. Nauck, C. Schaefer, M. Schattschneider, D. Stahl, H. Valentin, P. Heuschmann, A. L. Hofmann, S. Jiru‐Hillmann, J. P. Reese, S. Herold, P. Heuschmann, R. Heyder, W. Hoffmann, T. Illig, S. Schreiber, J. J. Vehreschild, M. Witzenrath   +190 more
wiley   +1 more source

Experiences of pacing to reduce symptoms among adults living with Long COVID in Canada, Ireland, the United Kingdom and the United States

Discover Public Health
Background Long COVID is a multisystem condition that negatively impacts daily function. Pacing is a self-management strategy to mitigate symptoms. Our aim was to describe experiences of pacing from the perspectives of adults living with Long COVID ...
Kiera McDuff, Darren A. Brown, Natalie St. Clair-Sullivan, Soo Chan Carusone, Kristine M. Erlandson, Lisa Avery, Ciaran Bannan, Colm Bergin, Angela M. Cheung, Susie Goulding, Richard Harding, Mary Kelly, Jessica M. Martin, Lisa McCorkell, Sarah O’Connell, Imelda O’Donovan, Margaret E. O’Hara, Niamh Roche, Ruth Stokes, Catherine Thomson, Liam Townsend, Jaimie H. Vera, Hannah Wei, Patricia Solomon, Kelly K. O’Brien   +24 more
doaj   +1 more source

The cost of primary care consultations associated with long COVID in non-hospitalised adults:a retrospective cohort study using UK primary care data [PDF]

, 2023
Background The economic impact of managing long COVID in primary care is unknown. We estimated the costs of primary care consultations associated with long COVID and explored the relationship between risk factors and costs.
Calvert, Melanie, Gokhale, Krishna, Guan, Naijie, Haroon, Shamil, Jackson, Louise J, Marshall, Tom, Matthews, Karen, Myles, Puja, Nirantharakumar, Krishnarajah, Subramanian, Anuradhaa, Tufts, Jake, Williams, Tim, Zemedikun, Dawit T   +12 more
core   +1 more source